Clincosm LogoSign in Get a demo

hematological neoplasms

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

Recruiting
  • Hematological Neoplasms
  • Recurrence
  • Peg interferon alfa-2b
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021

Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

Completed
  • Hematological Neoplasms
  • +19 more
  • Scottsdale, Arizona
  • +9 more
May 11, 2020

Granulocyte Transfusions in Hematological Febrile Neutropenia

Completed
  • Neutropenia
  • +6 more
    • Rome, Italy
      Catholic University of Sacred Heart
    Sep 5, 2015

    First Relapse After Participation In First Line HOVON-49/50

    Completed
    • Multiple Myeloma
    • Hematological Neoplasms
    • Bergen Op Zoom, Netherlands
    • +8 more
    Apr 15, 2015

    VALEO: A Post Authorization Study, Designed to Learn More About

    Completed
    • Multiple Myeloma
    • Hematological Neoplasms
    • 'S-Hertogenbosch, Netherlands
    • +43 more
    Jan 13, 2014

    Hematological Tumors, Tumors Trial in Rozzano (Filgrastim, Pegfilgrastim)

    Completed
    • Hematological Neoplasms
    • Tumors
    • Rozzano, Milan, Italy
      Istituto Clinico Humanitas
    Jun 28, 2013

    Hematological Tumors, Hematopoietic Stem Cell Transplantation Trial in Oklahoma City (Busulfex, Fludarabine, ALemtuzumab)

    Completed
    Has Results
    • Hematological Neoplasms
    • Hematopoietic Stem Cell Transplantation
    • Busulfex, Fludarabine, ALemtuzumab
    • Oklahoma City, Oklahoma
      University of Oklahoma Health Sciences Center
    Mar 23, 2011